Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy
Daniel Silverman(University of California, Los Angeles), Patricia A. Ganz(Los Angeles County Department of Public Health), Kari Waddell(UCLA Jonsson Comprehensive Cancer Center), Betty S. Pio(University of California, Los Angeles), Christine J. Dy(University of California, Los Angeles), Michael E. Phelps, Jasmine Lai(University of California, Los Angeles), Laura Petersen(APLA Health), Steven A. Castellon(University of California, Los Angeles), Laura Abraham(Cancer Prevention Institute of California)
Cited by 399
Related Papers
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment
|Journal of Clinical Oncology|2003|530